• Ananda-Rajah MR, Charles PG, Melvani S, Burrell LL, Johnson PD & Grayson ML (2008) Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia. Scandinavian Journal of Infectious Diseases 40, 293300.
  • Anstey NM, Currie BJ & Withnall KM (1992) Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia. Clinical Infectious Diseases 14, 8391.
  • Antibiotic Expert Group (2010) Respiratory tract infections: pneumonia. In: Therapeutic Guidelines: Antibiotic, 14th edn. (eds R Moulds et al.) Therapeutic Guidelines Ltd, Melbourne, pp. 221258.
  • Aujesky D, Auble TE, Yealy DM et al. (2005) Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. American Journal of Medicine 118, 384392.
  • Buising KL, Thursky KA, Black JF et al. (2007) Identifying severe community-acquired pneumonia in the emergency department: a simple clinical prediction tool. Emergency Medicine Australasia 19, 418426.
  • Charles PG, Whitby M, Fuller AJ et al. (2008a) The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clinical Infectious Diseases 46, 15131521.
  • Charles PG, Wolfe R, Whitby M et al. (2008b) SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clinical Infectious Diseases 47, 375384.
  • Davis JS, Cross GB, Charles PG, Currie BJ, Anstey NM & Cheng AC (2010) Pneumonia risk stratification in tropical Australia: does the SMART-COP score apply? Medical Journal of Australia 192, 133136.
  • Douglas MW, Lum G, Roy J, Fisher DA, Anstey NM & Currie BJ (2004) Epidemiology of community-acquired and nosocomial bloodstream infections in tropical Australia: a 12-month prospective study. Tropical Medicine and International Health 9, 795804.
  • Elliott JH, Anstey NM, Jacups SP, Fisher DA & Currie BJ (2005) Community-acquired pneumonia in northern Australia: low mortality in a tropical region using locally-developed treatment guidelines. International Journal of Infectious Diseases 9, 1520.
  • Fine MJ, Auble TE, Yealy DM et al. (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. New England Journal of Medicine 336, 243250.
  • Lim WS, van der Eerden MM, Laing R et al. (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58, 377382.
  • Man SY, Lee N, Ip M et al. (2007) Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax 62, 348353.
  • National Health and Medical Research Council (2001) Australian Alcohol Guidelines: Health Risks and Benefits. NHMRC, Canberra, Australia.
  • Tiruvoipati R, Lewis D, Haji K & Botha J (2010) High-flow nasal oxygen vs high-flow face mask: a randomized crossover trial in extubated patients. Journal of Critical Care 25(3), 463468.